Target intelligence / Profile preview

Lewis b histo-blood group antigen (Le(b))

Target
Le(b)
Molecular classification
Receptor, Carbohydrate antigen, Histo-blood group antigen, Glycan, Other
01

Overview

The Lewis b histo-blood group antigen (Le(b)) is a complex carbohydrate structure found on the surface of epithelial cells, particularly in the gastric mucosa, and in secretions like saliva [Marionneau S, et al., 2001, PMID: 12084972]. It is synthesized through the sequential action of fucosyltransferases, specifically the products of the FUT2 (Secretor) and FUT3 (Lewis) genes [IUPAC-IUB Joint Commission on Biochemical Nomenclature]. Biologically, Le(b) serves as a critical attachment site for various pathogens, most notably Helicobacter pylori, which utilizes its BabA adhesin to bind specifically to the Le(b) motif [Borén T, et al., 1993, PMID: 8259514]. This interaction is a primary factor in the colonization of the human stomach, leading to chronic inflammation, peptic ulcers, and an increased risk of gastric adenocarcinoma [Aspholm-Hurtig M, et al., 2004, PMID: 15273394]. Beyond H. pylori, Le(b) also acts as a receptor for certain strains of Norovirus and Rotavirus [Tan M, Jiang X., 2005, PMID: 15935300]. Therapeutic strategies targeting Le(b) focus on anti-adhesion molecules, such as glycomimetics or decoy oligosaccharides, which aim to block pathogen binding and facilitate clearance. Because Le(b) expression depends on an individual's genetic 'secretor' status, it also serves as a significant biomarker for susceptibility to specific gastrointestinal infections.

Other names
Lewis b antigenLe(b) antigenBlood group Lewis bFuc-alpha-1,2-Gal-beta-1,3-(Fuc-alpha-1,4)-GlcNAc
02

Mechanism of action

Competitive inhibition of pathogen adhesins, specifically the BabA protein of Helicobacter pylori, to prevent bacterial attachment to the gastric mucosa.

03

Biological functions

Cell adhesionPathogen bindingCell-cell recognitionImmune responseOther
04

Disease associations

InfectionInflammationCancerGastritisPeptic ulcer disease
05

Safety considerations

Potential interference with normal mucosal protective functionsVariation in expression across different ethnic populationsOff-target effects on normal cell-cell adhesion
06

Interacting drugs

Rebamipide

2 more in the full profile.

07

Biomarkers

Lewis phenotype (Le(a-b+))Secretor status (FUT2 genotype)

Beyond the preview

Go deeper on Lewis b histo-blood group antigen (Le(b)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lewis b histo-blood group antigen (Le(b)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call